ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Avian Influenza Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-11161
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Avian Influenza Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Avian Influenza Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-11161
Report
May 2025
Pages:183
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ceva
Zoetis Inc
Merck Animal Health
Avimex Animal Health
HVRI
Elanco
DHN
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
Sindh Poultry Vaccine Centre
JOVAC
Bio-Labs
Boehringer Ingelheim
CAHIC
Elanco Animal Health
PT Medion Farma Jaya
Pusvetma
IPB-Shigeta
Medion Farma Jaya
Caprifamarindo

Avian Influenza Vaccines Market Size

In 2024, the global market size of Avian Influenza Vaccines was estimated to be worth US$ 1100 million and is forecast to reach approximately US$ 1592 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.

Avian Influenza Vaccines Market

Avian Influenza Vaccines Market

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Avian Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avian Influenza Vaccines.
The Avian Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Avian Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Avian Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Avian Influenza Vaccines Market Report

Report Metric Details
Report Name Avian Influenza Vaccines Market
CAGR 5.5%
Segment by Type
  • H5+H7 Avian Influenza Vaccines
  • H9 Avian Influenza Vaccines
Segment by Application
  • Chicken
  • Duck & Goose
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, CAHIC, DHN, HVRI, CEVA, Elanco Animal Health, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, Sindh Poultry Vaccine Centre, Merck Animal Health, PT Medion Farma Jaya, Avimex Animal Health, JOVAC, Bio-Labs, Pusvetma, IPB-Shigeta, Medion Farma Jaya, Caprifamarindo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Avian Influenza Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Avian Influenza Vaccines sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Avian Influenza Vaccines Market?

Ans: Global top five manufacturers hold a share over 70%.

What is the Avian Influenza Vaccines Market share by region?

Ans: China is the largest market, with a share about 45%.

Who are the main players in the Avian Influenza Vaccines Market report?

Ans: The main players in the Avian Influenza Vaccines Market are Boehringer Ingelheim, CAHIC, DHN, HVRI, CEVA, Elanco Animal Health, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, Sindh Poultry Vaccine Centre, Merck Animal Health, PT Medion Farma Jaya, Avimex Animal Health, JOVAC, Bio-Labs, Pusvetma, IPB-Shigeta, Medion Farma Jaya, Caprifamarindo

What are the Application segmentation covered in the Avian Influenza Vaccines Market report?

Ans: The Applications covered in the Avian Influenza Vaccines Market report are Chicken, Duck & Goose, Other

What are the Type segmentation covered in the Avian Influenza Vaccines Market report?

Ans: The Types covered in the Avian Influenza Vaccines Market report are H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines

Recommended Reports

Poultry Vaccines

Influenza Vaccines

Livestock Disease Vaccines

Market trends :

Topic Trends
Global increasing avian flu outbreaks and rising global poultry consumption are driving demand for advanced and rapid-acting avian influenza vaccines, with governments prioritizing vaccination to protect food security and public health.
Type H5+H7 Avian Influenza Vaccines - h5+H7 avian influenza vaccines dominate the market due to their effectiveness against highly pathogenic strains and widespread adoption in large-scale poultry operations.
H9 Avian Influenza Vaccines - h9 avian influenza vaccines are gaining traction in regions where h9 subtype outbreaks are prevalent, supporting targeted immunization strategies.
Application Chicken - vaccination programs for chickens remain the largest application segment, driven by the need to safeguard commercial poultry production from economic losses.
Duck & Goose - demand for avian influenza vaccines in ducks and geese is rising as outbreaks increasingly affect waterfowl populations in key producing regions.
Other - other avian species are being included in vaccination strategies as part of broader biosecurity measures to control cross-species transmission.
Region APAC - china leads the global avian influenza vaccines market, accounting for nearly half of global demand due to large-scale poultry farming and frequent outbreaks.
North America - north america is expanding vaccination coverage in response to recent avian flu incidents and regulatory focus on preventing zoonotic transmission.
EMEA - emea is experiencing increased adoption of avian influenza vaccines as governments implement stricter animal health regulations and surveillance.
LATAM - latam is witnessing gradual growth in vaccine uptake as poultry production expands and regional outbreaks prompt preventive measures.
1 Study Coverage
1.1 Avian Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Avian Influenza Vaccines Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Market by Application
1.3.1 Global Avian Influenza Vaccines Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Avian Influenza Vaccines Market Size Estimates and Forecasts
2.1.1 Global Avian Influenza Vaccines Revenue 2020-2031
2.1.2 Global Avian Influenza Vaccines Sales 2020-2031
2.2 Avian Influenza Vaccines Market Size by Region: 2024 Versus 2031
2.3 Avian Influenza Vaccines Sales by Region (2020-2031)
2.3.1 Global Avian Influenza Vaccines Sales by Region: 2020-2025
2.3.2 Global Avian Influenza Vaccines Sales Forecast by Region (2026-2031)
2.3.3 Global Avian Influenza Vaccines Sales Market Share by Region (2020-2031)
2.4 Avian Influenza Vaccines Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Avian Influenza Vaccines Revenue by Region: 2020-2025
2.4.2 Global Avian Influenza Vaccines Revenue Forecast by Region (2026-2031)
2.4.3 Global Avian Influenza Vaccines Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Avian Influenza Vaccines Sales by Type (2020-2031)
3.1.1.1 Global Avian Influenza Vaccines Sales Volume by Type (2020-2031)
3.1.1.2 Global Avian Influenza Vaccines Sales Market Share by Type (2020-2031)
3.1.2 Global Avian Influenza Vaccines Revenue by Type (2020-2031)
3.1.2.1 Global Avian Influenza Vaccines Revenue by Type (2020-2031)
3.1.2.2 Global Avian Influenza Vaccines Revenue Market Share by Type (2020-2031)
3.1.3 Avian Influenza Vaccines Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Avian Influenza Vaccines Sales by Application (2020-2031)
3.2.1.1 Global Avian Influenza Vaccines Sales Volume by Application (2020-2031)
3.2.1.2 Global Avian Influenza Vaccines Sales Market Share by Application (2020-2031)
3.2.2 Global Avian Influenza Vaccines Revenue by Application (2020-2031)
3.2.2.1 Global Avian Influenza Vaccines Revenue by Application (2020-2031)
3.2.2.2 Global Avian Influenza Vaccines Revenue Market Share by Application (2020-2031)
3.2.3 Avian Influenza Vaccines Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 H5+H7 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application
3.3.2 H9 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application
4 Global Avian Influenza Vaccines by Manufacturers
4.1 Global Top Avian Influenza Vaccines Manufacturers by Sales (2020-2025)
4.1.1 Global Avian Influenza Vaccines Sales by Manufacturer (2020-2025)
4.1.2 Global Avian Influenza Vaccines Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Avian Influenza Vaccines Manufacturers by Revenue (2020-2025)
4.2.1 Global Avian Influenza Vaccines Revenue by Manufacturer (2020-2025)
4.2.2 Global Avian Influenza Vaccines Revenue Share by Manufacturer (2020-2025)
4.3 Global Avian Influenza Vaccines Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Avian Influenza Vaccines Manufacturers Covered: Ranking by Revenue
4.4.2 Global Avian Influenza Vaccines Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Avian Influenza Vaccines Manufacturing Base Distribution, Product Type
4.5.1 Avian Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Avian Influenza Vaccines Market
4.5.3 Manufacturers Avian Influenza Vaccines Product Type and Application
4.5.4 H5+H7 Avian Influenza Vaccines Market Sales of Avian Influenza Vaccines by Manufacturer
4.5.5 H9 Avian Influenza Vaccines Market Sales of Avian Influenza Vaccines by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Boehringer Ingelheim
5.1.1 Boehringer Ingelheim Company Information
5.1.2 Boehringer Ingelheim Description, Business Overview
5.1.3 Boehringer Ingelheim Avian Influenza Vaccines Products Offered
5.1.4 Boehringer Ingelheim Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Boehringer Ingelheim Avian Influenza Vaccines Sales by Product in 2024
5.1.6 Boehringer Ingelheim Avian Influenza Vaccines Sales by Application in 2024
5.1.7 Boehringer Ingelheim Avian Influenza Vaccines Sales by Geographic Area in 2024
5.1.8 Boehringer Ingelheim Recent Developments
5.2 CAHIC
5.2.1 CAHIC Company Information
5.2.2 CAHIC Description, Business Overview
5.2.3 CAHIC Avian Influenza Vaccines Products Offered
5.2.4 CAHIC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.2.5 CAHIC Avian Influenza Vaccines Sales by Product in 2024
5.2.6 CAHIC Avian Influenza Vaccines Sales by Application in 2024
5.2.7 CAHIC Avian Influenza Vaccines Sales by Geographic Area in 2024
5.2.8 CAHIC Recent Developments
5.3 DHN
5.3.1 DHN Company Information
5.3.2 DHN Description, Business Overview
5.3.3 DHN Avian Influenza Vaccines Products Offered
5.3.4 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.3.5 DHN Avian Influenza Vaccines Sales by Product in 2024
5.3.6 DHN Avian Influenza Vaccines Sales by Application in 2024
5.3.7 DHN Avian Influenza Vaccines Sales by Geographic Area in 2024
5.3.8 DHN Recent Developments
5.4 HVRI
5.4.1 HVRI Company Information
5.4.2 HVRI Description, Business Overview
5.4.3 HVRI Avian Influenza Vaccines Products Offered
5.4.4 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.4.5 HVRI Avian Influenza Vaccines Sales by Product in 2024
5.4.6 HVRI Avian Influenza Vaccines Sales by Application in 2024
5.4.7 HVRI Avian Influenza Vaccines Sales by Geographic Area in 2024
5.4.8 HVRI Recent Developments
5.5 CEVA
5.5.1 CEVA Company Information
5.5.2 CEVA Description, Business Overview
5.5.3 CEVA Avian Influenza Vaccines Products Offered
5.5.4 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.5.5 CEVA Avian Influenza Vaccines Sales by Product in 2024
5.5.6 CEVA Avian Influenza Vaccines Sales by Application in 2024
5.5.7 CEVA Avian Influenza Vaccines Sales by Geographic Area in 2024
5.5.8 CEVA Recent Developments
5.6 Elanco Animal Health
5.6.1 Elanco Animal Health Company Information
5.6.2 Elanco Animal Health Description, Business Overview
5.6.3 Elanco Animal Health Avian Influenza Vaccines Products Offered
5.6.4 Elanco Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Elanco Animal Health Avian Influenza Vaccines Sales by Product in 2024
5.6.6 Elanco Animal Health Avian Influenza Vaccines Sales by Application in 2024
5.6.7 Elanco Animal Health Avian Influenza Vaccines Sales by Geographic Area in 2024
5.6.8 Elanco Animal Health Recent Developments
5.7 Zoetis
5.7.1 Zoetis Company Information
5.7.2 Zoetis Description, Business Overview
5.7.3 Zoetis Avian Influenza Vaccines Products Offered
5.7.4 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Zoetis Avian Influenza Vaccines Sales by Product in 2024
5.7.6 Zoetis Avian Influenza Vaccines Sales by Application in 2024
5.7.7 Zoetis Avian Influenza Vaccines Sales by Geographic Area in 2024
5.7.8 Zoetis Recent Developments
5.8 FATRO
5.8.1 FATRO Company Information
5.8.2 FATRO Description, Business Overview
5.8.3 FATRO Avian Influenza Vaccines Products Offered
5.8.4 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.8.5 FATRO Avian Influenza Vaccines Sales by Product in 2024
5.8.6 FATRO Avian Influenza Vaccines Sales by Application in 2024
5.8.7 FATRO Avian Influenza Vaccines Sales by Geographic Area in 2024
5.8.8 FATRO Recent Developments
5.9 Kyoto Biken
5.9.1 Kyoto Biken Company Information
5.9.2 Kyoto Biken Description, Business Overview
5.9.3 Kyoto Biken Avian Influenza Vaccines Products Offered
5.9.4 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Kyoto Biken Avian Influenza Vaccines Sales by Product in 2024
5.9.6 Kyoto Biken Avian Influenza Vaccines Sales by Application in 2024
5.9.7 Kyoto Biken Avian Influenza Vaccines Sales by Geographic Area in 2024
5.9.8 Kyoto Biken Recent Developments
5.10 CAVAC
5.10.1 CAVAC Company Information
5.10.2 CAVAC Description, Business Overview
5.10.3 CAVAC Avian Influenza Vaccines Products Offered
5.10.4 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.10.5 CAVAC Avian Influenza Vaccines Sales by Product in 2024
5.10.6 CAVAC Avian Influenza Vaccines Sales by Application in 2024
5.10.7 CAVAC Avian Influenza Vaccines Sales by Geographic Area in 2024
5.10.8 CAVAC Recent Developments
5.11 Ringpu Biology
5.11.1 Ringpu Biology Company Information
5.11.2 Ringpu Biology Description, Business Overview
5.11.3 Ringpu Biology Avian Influenza Vaccines Products Offered
5.11.4 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Ringpu Biology Avian Influenza Vaccines Sales by Product in 2024
5.11.6 Ringpu Biology Avian Influenza Vaccines Sales by Application in 2024
5.11.7 Ringpu Biology Avian Influenza Vaccines Sales by Geographic Area in 2024
5.11.8 Ringpu Biology Recent Developments
5.12 Vaksindo
5.12.1 Vaksindo Company Information
5.12.2 Vaksindo Description, Business Overview
5.12.3 Vaksindo Avian Influenza Vaccines Products Offered
5.12.4 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Vaksindo Avian Influenza Vaccines Sales by Product in 2024
5.12.6 Vaksindo Avian Influenza Vaccines Sales by Application in 2024
5.12.7 Vaksindo Avian Influenza Vaccines Sales by Geographic Area in 2024
5.12.8 Vaksindo Recent Developments
5.13 Sindh Poultry Vaccine Centre
5.13.1 Sindh Poultry Vaccine Centre Company Information
5.13.2 Sindh Poultry Vaccine Centre Description, Business Overview
5.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Products Offered
5.13.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales by Product in 2024
5.13.6 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales by Application in 2024
5.13.7 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales by Geographic Area in 2024
5.13.8 Sindh Poultry Vaccine Centre Recent Developments
5.14 Merck Animal Health
5.14.1 Merck Animal Health Company Information
5.14.2 Merck Animal Health Description, Business Overview
5.14.3 Merck Animal Health Avian Influenza Vaccines Products Offered
5.14.4 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Merck Animal Health Avian Influenza Vaccines Sales by Product in 2024
5.14.6 Merck Animal Health Avian Influenza Vaccines Sales by Application in 2024
5.14.7 Merck Animal Health Avian Influenza Vaccines Sales by Geographic Area in 2024
5.14.8 Merck Animal Health Recent Developments
5.15 PT Medion Farma Jaya
5.15.1 PT Medion Farma Jaya Company Information
5.15.2 PT Medion Farma Jaya Description, Business Overview
5.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Products Offered
5.15.4 PT Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.15.5 PT Medion Farma Jaya Avian Influenza Vaccines Sales by Product in 2024
5.15.6 PT Medion Farma Jaya Avian Influenza Vaccines Sales by Application in 2024
5.15.7 PT Medion Farma Jaya Avian Influenza Vaccines Sales by Geographic Area in 2024
5.15.8 PT Medion Farma Jaya Recent Developments
5.16 Avimex Animal Health
5.16.1 Avimex Animal Health Company Information
5.16.2 Avimex Animal Health Description, Business Overview
5.16.3 Avimex Animal Health Avian Influenza Vaccines Products Offered
5.16.4 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Avimex Animal Health Avian Influenza Vaccines Sales by Product in 2024
5.16.6 Avimex Animal Health Avian Influenza Vaccines Sales by Application in 2024
5.16.7 Avimex Animal Health Avian Influenza Vaccines Sales by Geographic Area in 2024
5.16.8 Avimex Animal Health Recent Developments
5.17 JOVAC
5.17.1 JOVAC Company Information
5.17.2 JOVAC Description, Business Overview
5.17.3 JOVAC Avian Influenza Vaccines Products Offered
5.17.4 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.17.5 JOVAC Avian Influenza Vaccines Sales by Product in 2024
5.17.6 JOVAC Avian Influenza Vaccines Sales by Application in 2024
5.17.7 JOVAC Avian Influenza Vaccines Sales by Geographic Area in 2024
5.17.8 JOVAC Recent Developments
5.18 Bio-Labs
5.18.1 Bio-Labs Company Information
5.18.2 Bio-Labs Description, Business Overview
5.18.3 Bio-Labs Avian Influenza Vaccines Products Offered
5.18.4 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Bio-Labs Avian Influenza Vaccines Sales by Product in 2024
5.18.6 Bio-Labs Avian Influenza Vaccines Sales by Application in 2024
5.18.7 Bio-Labs Avian Influenza Vaccines Sales by Geographic Area in 2024
5.18.8 Bio-Labs Recent Developments
5.19 Pusvetma
5.19.1 Pusvetma Company Information
5.19.2 Pusvetma Description, Business Overview
5.19.3 Pusvetma Avian Influenza Vaccines Products Offered
5.19.4 Pusvetma Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Pusvetma Avian Influenza Vaccines Sales by Product in 2024
5.19.6 Pusvetma Avian Influenza Vaccines Sales by Application in 2024
5.19.7 Pusvetma Avian Influenza Vaccines Sales by Geographic Area in 2024
5.19.8 Pusvetma Recent Developments
5.20 IPB-Shigeta
5.20.1 IPB-Shigeta Company Information
5.20.2 IPB-Shigeta Description, Business Overview
5.20.3 IPB-Shigeta Avian Influenza Vaccines Products Offered
5.20.4 IPB-Shigeta Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.20.5 IPB-Shigeta Avian Influenza Vaccines Sales by Product in 2024
5.20.6 IPB-Shigeta Avian Influenza Vaccines Sales by Application in 2024
5.20.7 IPB-Shigeta Avian Influenza Vaccines Sales by Geographic Area in 2024
5.20.8 IPB-Shigeta Recent Developments
5.21 Medion Farma Jaya
5.21.1 Medion Farma Jaya Company Information
5.21.2 Medion Farma Jaya Description, Business Overview
5.21.3 Medion Farma Jaya Avian Influenza Vaccines Products Offered
5.21.4 Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.21.5 Medion Farma Jaya Avian Influenza Vaccines Sales by Product in 2024
5.21.6 Medion Farma Jaya Avian Influenza Vaccines Sales by Application in 2024
5.21.7 Medion Farma Jaya Avian Influenza Vaccines Sales by Geographic Area in 2024
5.21.8 Medion Farma Jaya Recent Developments
5.22 Caprifamarindo
5.22.1 Caprifamarindo Company Information
5.22.2 Caprifamarindo Description, Business Overview
5.22.3 Caprifamarindo Avian Influenza Vaccines Products Offered
5.22.4 Caprifamarindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2020-2025)
5.22.5 Caprifamarindo Avian Influenza Vaccines Sales by Product in 2024
5.22.6 Caprifamarindo Avian Influenza Vaccines Sales by Application in 2024
5.22.7 Caprifamarindo Avian Influenza Vaccines Sales by Geographic Area in 2024
5.22.8 Caprifamarindo Recent Developments
6 North America
6.1 North America Avian Influenza Vaccines Market Size YoY Growth 2020-2031
6.2 North America Avian Influenza Vaccines Market Facts & Figures by Country
6.2.1 North America Avian Influenza Vaccines Sales by Country (2020-2031)
6.2.2 North America Avian Influenza Vaccines Revenue by Country (2020-2031)
6.3 North America Avian Influenza Vaccines Sales by Type (2020-2025)
6.4 North America Avian Influenza Vaccines Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Avian Influenza Vaccines Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Avian Influenza Vaccines Market Facts & Figures by Region
7.2.1 Asia-Pacific Avian Influenza Vaccines Sales by Region (2020-2031)
7.2.2 Asia-Pacific Avian Influenza Vaccines Revenue by Region (2020-2031)
7.3 Asia-Pacific Avian Influenza Vaccines Sales by Type (2020-2025)
7.4 Asia-Pacific Avian Influenza Vaccines Sales by Application (2020-2025)
8 Europe
8.1 Europe Avian Influenza Vaccines Market Size YoY Growth 2020-2031
8.2 Europe Avian Influenza Vaccines Market Facts & Figures by Country
8.2.1 Europe Avian Influenza Vaccines Sales by Country (2020-2031)
8.2.2 Europe Avian Influenza Vaccines Revenue by Country (2020-2031)
8.3 Europe Avian Influenza Vaccines Sales by Type (2020-2025)
8.4 Europe Avian Influenza Vaccines Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Avian Influenza Vaccines Market Size YoY Growth 2020-2031
9.2 Latin America Avian Influenza Vaccines Market Facts & Figures by Country
9.2.1 Latin America Avian Influenza Vaccines Sales by Country (2020-2031)
9.2.2 Latin America Avian Influenza Vaccines Revenue by Country (2020-2031)
9.3 Latin America Avian Influenza Vaccines Sales by Type (2020-2025)
9.4 Latin America Avian Influenza Vaccines Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Avian Influenza Vaccines Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country
10.2.1 Middle East and Africa Avian Influenza Vaccines Sales by Country (2020-2031)
10.2.2 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2020-2031)
10.3 Middle East and Africa Avian Influenza Vaccines Sales by Type (2020-2025)
10.4 Middle East and Africa Avian Influenza Vaccines Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Avian Influenza Vaccines Supply Chain Analysis
11.2 Avian Influenza Vaccines Key Raw Materials and Upstream Suppliers
11.3 Avian Influenza Vaccines Clients Analysis
11.4 Avian Influenza Vaccines Sales Channel and Sales Model Analysis
11.4.1 Avian Influenza Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Avian Influenza Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Avian Influenza Vaccines Distributors
12 Avian Influenza Vaccines Market Dynamics
12.1 Avian Influenza Vaccines Industry Trends
12.2 Avian Influenza Vaccines Market Drivers
12.3 Avian Influenza Vaccines Market Challenges
12.4 Avian Influenza Vaccines Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Ceva
Zoetis Inc
Merck Animal Health
Avimex Animal Health
HVRI
Elanco
DHN
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
Sindh Poultry Vaccine Centre
JOVAC
Bio-Labs
Boehringer Ingelheim
CAHIC
Elanco Animal Health
PT Medion Farma Jaya
Pusvetma
IPB-Shigeta
Medion Farma Jaya
Caprifamarindo
List of Tables
 Table 1. Global Avian Influenza Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Avian Influenza Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Avian Influenza Vaccines Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Avian Influenza Vaccines Sales by Region (2020-2025) & (M Doses)
 Table 5. Global Avian Influenza Vaccines Sales Forecast by Region (2026-2031) & (M Doses)
 Table 6. Global Avian Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Avian Influenza Vaccines Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Avian Influenza Vaccines Sales Volume by Type (2020-2025) & (M Doses)
 Table 9. Global Avian Influenza Vaccines Sales Volume by Type (2026-2031) & (M Doses)
 Table 10. Global Avian Influenza Vaccines Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Avian Influenza Vaccines Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Avian Influenza Vaccines Sales Volume by Application (2020-2025) & (M Doses)
 Table 13. Global Avian Influenza Vaccines Sales Volume by Application (2026-2031) & (M Doses)
 Table 14. Global Avian Influenza Vaccines Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Avian Influenza Vaccines Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Avian Influenza Vaccines Sales by Manufacturer (2020-2025) & (M Doses)
 Table 17. Global Avian Influenza Vaccines Sales Share by Manufacturer (2020-2025)
 Table 18. Avian Influenza Vaccines Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Avian Influenza Vaccines Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Avian Influenza Vaccines Price (2020-2025) & (USD/K Doses)
 Table 21. Ranking of Global Top Avian Influenza Vaccines Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2024)
 Table 24. Avian Influenza Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Avian Influenza Vaccines Market
 Table 26. Manufacturers Avian Influenza Vaccines Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Boehringer Ingelheim Company Information
 Table 29. Boehringer Ingelheim Description and Business Overview
 Table 30. Boehringer Ingelheim Avian Influenza Vaccines Product
 Table 31. Boehringer Ingelheim Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 32. Boehringer Ingelheim Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 33. Boehringer Ingelheim Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 34. Boehringer Ingelheim Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 35. Boehringer Ingelheim Recent Developments
 Table 36. CAHIC Company Information
 Table 37. CAHIC Description and Business Overview
 Table 38. CAHIC Avian Influenza Vaccines Product
 Table 39. CAHIC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 40. CAHIC Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 41. CAHIC Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 42. CAHIC Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 43. CAHIC Recent Developments
 Table 44. DHN Company Information
 Table 45. DHN Description and Business Overview
 Table 46. DHN Avian Influenza Vaccines Product
 Table 47. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 48. DHN Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 49. DHN Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 50. DHN Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 51. DHN Recent Developments
 Table 52. HVRI Company Information
 Table 53. HVRI Description and Business Overview
 Table 54. HVRI Avian Influenza Vaccines Product
 Table 55. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 56. HVRI Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 57. HVRI Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 58. HVRI Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 59. HVRI Recent Developments
 Table 60. CEVA Company Information
 Table 61. CEVA Description and Business Overview
 Table 62. CEVA Avian Influenza Vaccines Product
 Table 63. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 64. CEVA Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 65. CEVA Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 66. CEVA Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 67. CEVA Recent Developments
 Table 68. Elanco Animal Health Company Information
 Table 69. Elanco Animal Health Description and Business Overview
 Table 70. Elanco Animal Health Avian Influenza Vaccines Product
 Table 71. Elanco Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 72. Elanco Animal Health Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 73. Elanco Animal Health Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 74. Elanco Animal Health Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 75. Elanco Animal Health Recent Developments
 Table 76. Zoetis Company Information
 Table 77. Zoetis Description and Business Overview
 Table 78. Zoetis Avian Influenza Vaccines Product
 Table 79. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 80. Zoetis Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 81. Zoetis Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 82. Zoetis Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 83. Zoetis Recent Developments
 Table 84. FATRO Company Information
 Table 85. FATRO Description and Business Overview
 Table 86. FATRO Avian Influenza Vaccines Product
 Table 87. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 88. FATRO Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 89. FATRO Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 90. FATRO Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 91. FATRO Recent Developments
 Table 92. Kyoto Biken Company Information
 Table 93. Kyoto Biken Description and Business Overview
 Table 94. Kyoto Biken Avian Influenza Vaccines Product
 Table 95. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 96. Kyoto Biken Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 97. Kyoto Biken Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 98. Kyoto Biken Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 99. Kyoto Biken Recent Developments
 Table 100. CAVAC Company Information
 Table 101. CAVAC Description and Business Overview
 Table 102. CAVAC Avian Influenza Vaccines Product
 Table 103. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 104. CAVAC Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 105. CAVAC Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 106. CAVAC Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 107. CAVAC Recent Developments
 Table 108. Ringpu Biology Company Information
 Table 109. Ringpu Biology Description and Business Overview
 Table 110. Ringpu Biology Avian Influenza Vaccines Product
 Table 111. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 112. Ringpu Biology Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 113. Ringpu Biology Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 114. Ringpu Biology Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 115. Ringpu Biology Recent Developments
 Table 116. Vaksindo Company Information
 Table 117. Vaksindo Description and Business Overview
 Table 118. Vaksindo Avian Influenza Vaccines Product
 Table 119. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 120. Vaksindo Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 121. Vaksindo Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 122. Vaksindo Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 123. Vaksindo Recent Developments
 Table 124. Sindh Poultry Vaccine Centre Company Information
 Table 125. Sindh Poultry Vaccine Centre Description and Business Overview
 Table 126. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product
 Table 127. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 128. Sindh Poultry Vaccine Centre Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 129. Sindh Poultry Vaccine Centre Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 130. Sindh Poultry Vaccine Centre Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 131. Sindh Poultry Vaccine Centre Recent Developments
 Table 132. Merck Animal Health Company Information
 Table 133. Merck Animal Health Description and Business Overview
 Table 134. Merck Animal Health Avian Influenza Vaccines Product
 Table 135. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 136. Merck Animal Health Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 137. Merck Animal Health Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 138. Merck Animal Health Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 139. Merck Animal Health Recent Developments
 Table 140. PT Medion Farma Jaya Company Information
 Table 141. PT Medion Farma Jaya Description and Business Overview
 Table 142. PT Medion Farma Jaya Avian Influenza Vaccines Product
 Table 143. PT Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 144. PT Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 145. PT Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 146. PT Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 147. PT Medion Farma Jaya Recent Developments
 Table 148. Avimex Animal Health Company Information
 Table 149. Avimex Animal Health Description and Business Overview
 Table 150. Avimex Animal Health Avian Influenza Vaccines Product
 Table 151. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 152. Avimex Animal Health Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 153. Avimex Animal Health Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 154. Avimex Animal Health Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 155. Avimex Animal Health Recent Developments
 Table 156. JOVAC Company Information
 Table 157. JOVAC Description and Business Overview
 Table 158. JOVAC Avian Influenza Vaccines Product
 Table 159. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 160. JOVAC Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 161. JOVAC Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 162. JOVAC Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 163. JOVAC Recent Developments
 Table 164. Bio-Labs Company Information
 Table 165. Bio-Labs Description and Business Overview
 Table 166. Bio-Labs Avian Influenza Vaccines Product
 Table 167. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 168. Bio-Labs Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 169. Bio-Labs Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 170. Bio-Labs Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 171. Bio-Labs Recent Developments
 Table 172. Pusvetma Company Information
 Table 173. Pusvetma Description and Business Overview
 Table 174. Pusvetma Avian Influenza Vaccines Product
 Table 175. Pusvetma Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 176. Pusvetma Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 177. Pusvetma Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 178. Pusvetma Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 179. Pusvetma Recent Developments
 Table 180. IPB-Shigeta Company Information
 Table 181. IPB-Shigeta Description and Business Overview
 Table 182. IPB-Shigeta Avian Influenza Vaccines Product
 Table 183. IPB-Shigeta Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 184. IPB-Shigeta Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 185. IPB-Shigeta Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 186. IPB-Shigeta Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 187. IPB-Shigeta Recent Developments
 Table 188. Medion Farma Jaya Company Information
 Table 189. Medion Farma Jaya Description and Business Overview
 Table 190. Medion Farma Jaya Avian Influenza Vaccines Product
 Table 191. Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 192. Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 193. Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 194. Medion Farma Jaya Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 195. Medion Farma Jaya Recent Developments
 Table 196. Caprifamarindo Company Information
 Table 197. Caprifamarindo Description and Business Overview
 Table 198. Caprifamarindo Avian Influenza Vaccines Product
 Table 199. Caprifamarindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
 Table 200. Caprifamarindo Sales Proportion of Avian Influenza Vaccines by Product in 2024
 Table 201. Caprifamarindo Sales Proportion of Avian Influenza Vaccines by Application in 2024
 Table 202. Caprifamarindo Sales Proportion of Avian Influenza Vaccines by Geographic Area in 2024
 Table 203. Caprifamarindo Recent Developments
 Table 204. North America Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
 Table 205. North America Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
 Table 206. North America Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 207. North America Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 208. North America Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 209. North America Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 210. Asia-Pacific Avian Influenza Vaccines Sales by Region (2020-2025) & (M Doses)
 Table 211. Asia-Pacific Avian Influenza Vaccines Sales by Region (2026-2031) & (M Doses)
 Table 212. Asia-Pacific Avian Influenza Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 213. Asia-Pacific Avian Influenza Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 214. Asia-Pacific Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 215. Asia-Pacific Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 216. Europe Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
 Table 217. Europe Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
 Table 218. Europe Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 219. Europe Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 220. Europe Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 221. Europe Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 222. Latin America Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
 Table 223. Latin America Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
 Table 224. Latin America Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 225. Latin America Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 226. Latin America Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 227. Latin America Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 228. Middle East and Africa Avian Influenza Vaccines Sales by Country (2020-2025) & (M Doses)
 Table 229. Middle East and Africa Avian Influenza Vaccines Sales by Country (2026-2031) & (M Doses)
 Table 230. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 231. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 232. Middle East and Africa Avian Influenza Vaccines Sales by Type (2020-2025) & (M Doses)
 Table 233. Middle East and Africa Avian Influenza Vaccines Sales by Application (2020-2025) & (M Doses)
 Table 234. Avian Influenza Vaccines Key Raw Materials, Industry Status and Trend
 Table 235. Avian Influenza Vaccines Key Raw Materials and Upstream Suppliers
 Table 236. Avian Influenza Vaccines Clients Status and Trend
 Table 237. Avian Influenza Vaccines Typical Clients
 Table 238. Avian Influenza Vaccines Distributors
 Table 239. Avian Influenza Vaccines Market Trends
 Table 240. Avian Influenza Vaccines Market Drivers
 Table 241. Avian Influenza Vaccines Market Challenges
 Table 242. Avian Influenza Vaccines Market Restraints
 Table 243. Research Programs/Design for This Report
 Table 244. Key Data Information from Secondary Sources
 Table 245. Key Data Information from Primary Sources
 Table 246. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Avian Influenza Vaccines Product Picture
 Figure 2. Global Avian Influenza Vaccines Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Avian Influenza Vaccines Sales Market Share by Type in 2024 & 2031
 Figure 4. H5+H7 Avian Influenza Vaccines Product Picture
 Figure 5. H9 Avian Influenza Vaccines Product Picture
 Figure 6. Global Avian Influenza Vaccines Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Avian Influenza Vaccines Sales Market Share by Application in 2024 & 2031
 Figure 8. Chicken
 Figure 9. Duck & Goose
 Figure 10. Other
 Figure 11. Avian Influenza Vaccines Report Years Considered
 Figure 12. Global Avian Influenza Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Avian Influenza Vaccines Market Size 2020-2031 (US$ Million)
 Figure 14. Global Avian Influenza Vaccines Sales 2020-2031 (M Doses)
 Figure 15. Global Avian Influenza Vaccines Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Avian Influenza Vaccines Revenue Market Share by Region (2020-2031)
 Figure 17. Global Avian Influenza Vaccines Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Avian Influenza Vaccines Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Avian Influenza Vaccines Average Selling Price (ASP) by Type (2020-2025) & (USD/K Doses)
 Figure 20. Global Avian Influenza Vaccines Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Avian Influenza Vaccines Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Avian Influenza Vaccines Average Selling Price (ASP) by Application (2020-2025) & (USD/K Doses)
 Figure 23. H5+H7 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application, 2024 VS 2031
 Figure 24. H9 Avian Influenza Vaccines of Avian Influenza Vaccines Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Avian Influenza Vaccines Sales Share by Manufacturer in 2024
 Figure 26. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. H5+H7 Avian Influenza Vaccines Market Sales Proportion by Manufacturer in 2024
 Figure 28. H9 Avian Influenza Vaccines Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Avian Influenza Vaccines Revenue 2020-2031 (US$ Million)
 Figure 30. North America Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Figure 31. North America Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Avian Influenza Vaccines Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Avian Influenza Vaccines Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Figure 37. Europe Avian Influenza Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Avian Influenza Vaccines Sales Market Share by Country (2020-2031)
 Figure 39. Europe Avian Influenza Vaccines Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Figure 41. Europe Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Avian Influenza Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Avian Influenza Vaccines Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Avian Influenza Vaccines Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Avian Influenza Vaccines Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Application (2020-2025)
 Figure 52. Avian Influenza Vaccines Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Avian Influenza Vaccines Raw Materials by Region in 2024
 Figure 54. Avian Influenza Vaccines Distribution Channels
 Figure 55. Global Avian Influenza Vaccines Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Avian Influenza Vaccines Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Avian Flu Treatment Market Insights Forecast to 2030
Global Newcastle Disease Vaccine Market Research Report 2025
Global Avian Pox Vaccine Market Research Report 2024
Global Live Poultry Vaccine Market Research Report 2025
Global Equine Influenza Vaccine Market Research Report 2024
Global Poultry Viral Disease Vaccines Market Research Report 2024
Global Canine Influenza Vaccine Market Research Report 2024
Global Poultry Vaccines Market Research Report 2025
Global Poultry and Livestock Vaccines Market Research Report 2025
Global Live type Poultry Vaccine Market Research Report 2025
Global Poultry Live Attenuated Vaccine Market Research Report 2024
Global Newcastle Disease Treatment Market Research Report 2024
Chicken Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Egg free Flu Vaccine Market Research Report 2024
Poultry Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poultry Live Vaccines Market Research Report 2025
Global Waterfowl Vaccines Market Research Report 2024
Chicken Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Livestock Vaccines and Poultry Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Flu Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions